DE60313998D1 - Schmerzfreie injektions-zubereitungen von 2-arylpropionsäuresalzen - Google Patents

Schmerzfreie injektions-zubereitungen von 2-arylpropionsäuresalzen

Info

Publication number
DE60313998D1
DE60313998D1 DE60313998T DE60313998T DE60313998D1 DE 60313998 D1 DE60313998 D1 DE 60313998D1 DE 60313998 T DE60313998 T DE 60313998T DE 60313998 T DE60313998 T DE 60313998T DE 60313998 D1 DE60313998 D1 DE 60313998D1
Authority
DE
Germany
Prior art keywords
pain
acid salts
free injection
injection preparations
arylpropionic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60313998T
Other languages
English (en)
Other versions
DE60313998T2 (de
Inventor
Marco Maria Gentile
Maria Concetta Dragani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dompe SpA
Original Assignee
Dompe SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe SpA filed Critical Dompe SpA
Application granted granted Critical
Publication of DE60313998D1 publication Critical patent/DE60313998D1/de
Publication of DE60313998T2 publication Critical patent/DE60313998T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60313998T 2002-10-25 2003-10-22 Schmerzfreie injektions-zubereitungen von 2-arylpropionsäuresalzen Expired - Lifetime DE60313998T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02023954 2002-10-25
EP02023954 2002-10-25
PCT/EP2003/011689 WO2004037242A1 (en) 2002-10-25 2003-10-22 Painless injectable compositions containing salt of 2-arylpropionic acids

Publications (2)

Publication Number Publication Date
DE60313998D1 true DE60313998D1 (de) 2007-07-05
DE60313998T2 DE60313998T2 (de) 2008-01-31

Family

ID=32116228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60313998T Expired - Lifetime DE60313998T2 (de) 2002-10-25 2003-10-22 Schmerzfreie injektions-zubereitungen von 2-arylpropionsäuresalzen

Country Status (11)

Country Link
US (1) US7442832B2 (de)
EP (1) EP1558234B1 (de)
CN (1) CN1329029C (de)
AT (1) ATE362756T1 (de)
AU (1) AU2003274060A1 (de)
DE (1) DE60313998T2 (de)
ES (1) ES2287519T3 (de)
HK (1) HK1084336A1 (de)
MX (1) MXPA05004377A (de)
RU (1) RU2340334C2 (de)
WO (1) WO2004037242A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2526996T3 (da) 2002-12-20 2019-12-02 Xeris Pharmaceuticals Inc Formulering til intrakutan injektion
WO2007142707A1 (en) * 2006-02-06 2007-12-13 Pharmaceutical Solutions, Inc. Non-steroidal anti-inflammatory oral powder and liquid preparations for administration to animals
FR2950533B1 (fr) * 2009-09-28 2012-01-13 Maco Pharma Sa Formulation liquide, stable, prete a l'emploi de ketoprofene
US20120046225A1 (en) 2010-07-19 2012-02-23 The Regents Of The University Of Colorado, A Body Corporate Stable glucagon formulations for the treatment of hypoglycemia
CN105853348B (zh) 2011-03-10 2019-08-30 Xeris药物公司 肠胃外注射用稳定溶液
WO2013067022A1 (en) 2011-10-31 2013-05-10 Xeris Pharmaceuticals, Inc. Formulations for the treatment of diabetes
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN102885766B (zh) * 2012-11-05 2014-06-18 西安德天药业股份有限公司 一种右旋酮洛芬注射液及其制备方法
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
KR102428675B1 (ko) 2014-08-06 2022-08-02 엑스에리스 파머수티클스, 인크. 페이스트의 피내 및／또는 피하 주사를 위한 주사기, 키트, 및 방법
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
EP4378463A2 (de) 2017-06-02 2024-06-05 Xeris Pharmaceuticals, Inc. Niederschlagsbeständige kleinmolekulare zubereitung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1277741B1 (it) 1995-12-28 1997-11-12 Dompe Spa Composizioni farmaceutiche parenterali contenenti sali di alchilammonio di acidi 2-arilpropionici
CN1260172A (zh) * 1998-12-18 2000-07-19 国家医药管理局上海医药工业研究院 右旋酮洛芬制剂
US6342530B1 (en) * 2000-11-14 2002-01-29 Farmacon-Il, Llc Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt

Also Published As

Publication number Publication date
RU2005115865A (ru) 2006-01-20
MXPA05004377A (es) 2005-07-26
CN1720037A (zh) 2006-01-11
US20060058386A1 (en) 2006-03-16
ES2287519T3 (es) 2007-12-16
WO2004037242A1 (en) 2004-05-06
DE60313998T2 (de) 2008-01-31
RU2340334C2 (ru) 2008-12-10
CN1329029C (zh) 2007-08-01
EP1558234B1 (de) 2007-05-23
HK1084336A1 (en) 2006-07-28
ATE362756T1 (de) 2007-06-15
US7442832B2 (en) 2008-10-28
AU2003274060A1 (en) 2004-05-13
EP1558234A1 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
HK1084336A1 (en) No pain injectable compositions containing salts of 2-arylpropionic acids
EA199700201A1 (ru) Парентеральные фармацевтические композиции, содержащие алкиламмониевые соли 2-арилпропиновых кислот
EA200701913A1 (ru) Лечение статином, омега-3 жирными кислотами и их комбинированным продуктом
ES2099022B1 (es) Composiciones farmaceuticas que contienen las sales de acido s(+)-2-(4-isobutilfenil) propionico con aminoacidos basicos.
TR200200252T2 (tr) Şimerik polipeptidler, bunların üretimi için yöntem ve kullanımı
EA200000331A1 (ru) Фармацевтические композиции, содержащие белок плазмы
DE69231359T2 (de) Ibuprofen-salz enthaltende pharmazeutische zusammensetzung
DE69622157T2 (de) Zusammensetzung zur verhinderung von osteolyse und metastasen
FI972744A (fi) Aminohappokokoonpanoja ja niiden käyttö kliinisessä ravinnossa
DE69818286D1 (de) Pyridylverbindungen und diese enthaltende pharmazeutische zubereitungen
DE69415018D1 (de) Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure
DE69900756T2 (de) Verwendung von hmg proteinen zur herstellung von arzneimitteln mit zytotoxischer wirkung
ATE401350T1 (de) Dentalzubereitungen enthaltend peptide, die das knochenwachstum fördern
DK0977560T3 (da) Ibuprofen-thioestere som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer (CoA-thioestere af arylpropionsyrer, aryleddikesyrer og salicylater som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer)
DE60110185D1 (de) Zusammensetzung und Verfahren zur parenteralen Anwendung von Ibuprofen-D,L-, oder L-Lysinat
UA93365C2 (ru) Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты)
WO2002058589A3 (en) Agents and methods for promoting bone growth
BRPI0415628A (pt) suspensões analgésicas para liberação controlada
DE69430416T2 (de) Zusammensetzungen aus Aminosäure zur Behandlung von Infektionen
BR9811954A (pt) ácidos 3-aril-succinamido-hidroxâmicos, processos para sua produção e preparações farmacêuticas contendo estas substâncias
BRPI0415630A (pt) suspensões analgésicas para liberação controlada
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
DE69208171T2 (de) Gallensäuren enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
IL117564A (en) Pharmaceutical and diagnostic compositions containing lysine derivatives
EA200300535A1 (ru) Способ получения антигенных структур, усиливающих специфическую перекрестную реактивность

Legal Events

Date Code Title Description
8364 No opposition during term of opposition